Circ_0003645 serves as miR-335-5p sponge to promote the biological process of diffuse large B-cell lymphoma by upregulating NFIB

References

• Li S, Young KH, Medeiros LJ. Diffuse large B-cell lymphoma. Pathology. 2018;50(1):74–87.
   PubMed Web of Science ®Google Scholar
• Tilly H, Gomes da Silva M, Vitolo U, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v116–125.
   PubMed Web of Science ®Google Scholar
• Friedberg JW. Relapsed/refractory diffuse large B-cell lymphoma. Hematology Am Soc Hematol Educ Program. 2011;2011:498–505.
   PubMed Web of Science ®Google Scholar
• Bobillo S, Joffe E, Lavery JA, et al. Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era. Blood. 2021;137(1):39–48.
   PubMedGoogle Scholar
• Miyazaki K. Treatment of diffuse large B-Cell lymphoma. J Clin Exp Hematop. 2016;56(2):79–88.
   PubMedGoogle Scholar
• Jamil MO, Mehta A. Diffuse large B-cell lymphoma: prognostic markers and their impact on therapy. Expert Rev Hematol. 2016;9(5):471–477.
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
   PubMed Web of Science ®Google Scholar
• Welden JR, Stamm S. Pre-mRNA structures forming circular RNAs. Biochim Biophys Acta Gene Regul Mech. 2019;1862(11–12):194410.
   PubMed Web of Science ®Google Scholar
• Tian Y, Xing Y, Zhang Z, et al. Bioinformatics analysis of key genes and circRNA-miRNA-mRNA regulatory network in gastric cancer. Biomed Res Int. 2020;2020:2862701.
   PubMedGoogle Scholar
• Tian M, Dong J, Yuan B, et al. Identification of potential circRNAs and circRNA-miRNA-mRNA regulatory network in the development of diabetic foot ulcers by integrated bioinformatics analysis. Int Wound J. 2021;18(3):323–331.
   PubMedGoogle Scholar
• Zhang ZY, Gao XH, Ma MY, et al. CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p/MAPK1 axis. Sci Rep. 2020;10(1):9024.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yu Y, Huang Z, et al. CircRNA-5692 inhibits the progression of hepatocellular carcinoma by sponging miR-328-5p to enhance DAB2IP expression. Cell Death Dis. 2019;10(12):900.
   PubMed Web of Science ®Google Scholar
• Deng W, Fu J, Wang T, et al. Hsa_circRNA_101036 acts as tumor-suppressor in oral squamous cell carcinoma cells via inducing endoplasmic reticulum stress. Eur Rev Med Pharmacol Sci. 2020;24(11):6111–6121.
   PubMedGoogle Scholar
• Liu W, Lei L, Liu X, et al. CircRNA_OTUD7A upregulates FOXP1 expression to facilitate the progression of diffuse large B-cell lymphoma via acting as a sponge of miR-431-5p. Genes Genomics. 2021;43(6):653–667.
   PubMedGoogle Scholar
• Chen X, Xie X, Zhou W. CircCFL1/MiR-107 axis targeting HMGB1 promotes the malignant progression of diffuse large B-Cell lymphoma tumors. Cancer Manag Res. 2020;12:9351–9362.
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhao Y, Shi C, et al. A circular RNA from APC inhibits the proliferation of diffuse large B-cell lymphoma by inactivating Wnt/β-catenin signaling via interacting with TET1 and miR-888. Aging. 2019;11(19):8068–8084.
   PubMedGoogle Scholar
• Zhang J, Ke S, Zheng W, et al. Hsa_circ_0003645 promotes breast cancer progression by regulating miR-139-3p/HMGB1 axis. Onco Targets Ther. 2020;13:10361–10372.
   PubMedGoogle Scholar
• An J, Shi H, Zhang N, et al. Elevation of circular RNA circ_0003645 forecasts unfavorable prognosis and facilitates cell progression via miR-1179/TMEM14A pathway in non-small cell lung cancer. Biochem Biophys Res Commun. 2019;511(4):921–925.
   PubMedGoogle Scholar
• Yu B, Wang B, Wu Z, et al. LncRNA SNHG8 promotes proliferation and inhibits apoptosis of diffuse large B-Cell lymphoma via sponging miR-335-5p. Front Oncol. 2021;11(650287):650287.
   PubMedGoogle Scholar
• Meng S, Zhou H, Feng Z, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94.
   PubMed Web of Science ®Google Scholar
• Zhang HD, Jiang LH, Sun DW, et al. CircRNA: a novel type of biomarker for cancer. Breast Cancer. 2018;25(1):1–7.
   PubMed Web of Science ®Google Scholar
• Wang X, Xiao H, Wu D, et al. miR-335-5p regulates cell cycle and metastasis in lung adenocarcinoma by targeting CCNB2. Onco Targets Ther. 2020;13:6255–6263.
   PubMed Web of Science ®Google Scholar
• Zhang D, Yang N. MiR-335-5p inhibits cell proliferation, migration and invasion in colorectal cancer through downregulating LDHB. J Buon. 2019;24(3):1128–1136.
   PubMedGoogle Scholar
• An Y, Cai H, Zhang Y, et al. circZMYM2 competed endogenously with miR-335-5p to regulate JMJD2C in pancreatic cancer. Cell Physiol Biochem. 2018;51(5):2224–2236.
   PubMedGoogle Scholar
• Sun L, Fang Y, Wang X, et al. miR-302a inhibits metastasis and cetuximab resistance in colorectal cancer by targeting NFIB and CD44. Theranostics. 2019;9(26):8409–8425.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhan F, Li D, et al. RGMB-AS1/miR-22-3p/NFIB axis contributes to the progression of gastric cancer. Neoplasma. 2020;67(3):484–491.
   PubMed Web of Science ®Google Scholar
• Moon HG, Hwang KT, Kim JA, et al. NFIB is a potential target for estrogen receptor-negative breast cancers. Mol Oncol. 2011;5(6):538–544.
   PubMedGoogle Scholar
• Wang N, Yuan J, Liu F, et al. NFIB promotes the migration and progression of kidney renal clear cell carcinoma by regulating PINK1 transcription. PeerJ. 2021;9:e10848.
   PubMedGoogle Scholar
• Liu RZ, Vo TM, Jain S, et al. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer. J Pathol. 2019;247(2):186–198.
   PubMed Web of Science ®Google Scholar
• Wu C, Zhu X, Liu W, et al. NFIB promotes cell growth, aggressiveness, metastasis and EMT of gastric cancer through the akt/Stat3 signaling pathway. Oncol Rep. 2018;40(3):1565–1573.
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen J, Yuan W, et al. Nuclear factor I/B promotes colorectal cancer cell proliferation, epithelial-mesenchymal transition and 5-fluorouracil resistance. Cancer Sci. 2019;110(1):86–98.
   PubMed Web of Science ®Google Scholar
• Tian M, Li Y, Zheng W, et al. LncRNA PCAT1 enhances cell proliferation, migration and invasion by miR-508-3p/NFIB axis in diffuse large B-cell lymphoma. Eur Rev Med Pharmacol Sci. 2021;25(6):2567–2576.
   PubMedGoogle Scholar